ZA200004819B - Mutant recombinant allergens. - Google Patents

Mutant recombinant allergens.

Info

Publication number
ZA200004819B
ZA200004819B ZA200004819A ZA200004819A ZA200004819B ZA 200004819 B ZA200004819 B ZA 200004819B ZA 200004819 A ZA200004819 A ZA 200004819A ZA 200004819 A ZA200004819 A ZA 200004819A ZA 200004819 B ZA200004819 B ZA 200004819B
Authority
ZA
South Africa
Prior art keywords
allergens
recombinant allergens
mutant recombinant
disclosed
recombinant
Prior art date
Application number
ZA200004819A
Other languages
English (en)
Inventor
Hans Henrik Ipsen
Michael Dho Spangfort
Jorgen Nedergaard Larsen
Original Assignee
Alk Abello As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8092687&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA200004819(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Alk Abello As filed Critical Alk Abello As
Publication of ZA200004819B publication Critical patent/ZA200004819B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Botany (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA200004819A 1998-03-16 2000-09-12 Mutant recombinant allergens. ZA200004819B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK36498 1998-03-16

Publications (1)

Publication Number Publication Date
ZA200004819B true ZA200004819B (en) 2001-05-30

Family

ID=8092687

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200004819A ZA200004819B (en) 1998-03-16 2000-09-12 Mutant recombinant allergens.

Country Status (20)

Country Link
US (1) US20040091500A1 (da)
EP (1) EP1062341B1 (da)
JP (1) JP2002506648A (da)
KR (1) KR20010041918A (da)
CN (1) CN1332029C (da)
AT (1) ATE408690T1 (da)
AU (1) AU749749B2 (da)
CA (1) CA2323687C (da)
DE (1) DE69939584D1 (da)
DK (1) DK1062341T3 (da)
ES (1) ES2313776T3 (da)
HK (1) HK1033591A1 (da)
HU (1) HUP0101464A3 (da)
IL (2) IL138339A0 (da)
NO (1) NO328354B1 (da)
NZ (1) NZ506665A (da)
PL (1) PL194804B1 (da)
PT (1) PT1062341E (da)
WO (1) WO1999047680A1 (da)
ZA (1) ZA200004819B (da)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001254620A1 (en) * 2000-04-28 2001-11-12 Novozymes A/S Lipolytic enzyme variant
IT1318690B1 (it) * 2000-09-12 2003-08-27 Consiglio Nazionale Ricerche Varianti dell'allergene maggiore par j 2 di parietaria judaica.
IT1318692B1 (it) * 2000-09-12 2003-08-27 Consiglio Nazionale Ricerche Varianti di proteine allergeniche di phleum pratense.
DK1340085T3 (da) * 2000-10-17 2008-12-01 Besst Test Aps Assay til direkte detektion af en biologisk celle i en legemsvæskepröve
NZ525820A (en) * 2000-11-16 2005-01-28 Alk Abello As Mutant allergens
DK1219300T3 (da) * 2000-12-28 2007-03-05 Biomay Prod & Handel Behandling af allergi
CN1610556A (zh) * 2001-03-02 2005-04-27 洛克菲勒大学 保留天然变应原的免疫原性并具减弱的变应原性的重组杂合变应原构建体
EP1436627A2 (en) * 2001-10-05 2004-07-14 Novozymes A/S Kit for predicting binding of a specific antibody to a potential immunogen and method of screening
EP1504089A2 (en) * 2002-05-16 2005-02-09 Alk Abell A/S Allergen mutants
PL375218A1 (en) * 2002-11-01 2005-11-28 Alk-Abello A/S Recombinant protein variants
MXPA05005528A (es) 2002-11-26 2006-04-05 Alk Abello As Producto farmaceutico de alergeno.
CA2516291C (en) 2003-02-28 2012-02-14 Alk-Abello A/S Dosage form having a saccharide matrix
US8012505B2 (en) 2003-02-28 2011-09-06 Alk-Abello A/S Dosage form having a saccharide matrix
BRPI0417264A (pt) 2003-12-19 2007-03-06 Alk Abello As processos para a preparação de uma batelada de um ingrediente farmacêutico ativo, um recipiente compreendendo criogránulos de um produto alérgeno, e um criogránulo de um produto alérgeno
EP1933867A1 (en) 2005-10-04 2008-06-25 Alk-Abello A/S Solid vaccine formulation
ITMI20052517A1 (it) 2005-12-29 2007-06-30 Lofarma Spa Varianbtio ipoallergeniche dell'allergene maggiore bet v 1 di polline di betula verrucosa
EP2010645A4 (en) * 2006-04-20 2009-05-06 Univ Singapore RECOMBINANT LACTOBACILLUS AND USE THEREOF
MX2009008620A (es) * 2007-02-15 2009-10-22 Mannkind Corp Un metodo para mejorar la respuesta de celulas t.
EP1974746B1 (en) 2007-03-28 2012-01-11 Alk-Abelló A/S Use of an adjuvanted allergy vaccine formulation for parenteral administration
EP2028188A1 (en) * 2007-08-21 2009-02-25 Biomay AG Hypoallergenic molecules
DE202008006598U1 (de) 2008-04-11 2008-10-02 Alk-Abelló A/S Allergie-Impfstoff-Formulierung zur mucosalen Verabreichung
EP2442828B1 (en) 2009-06-19 2016-08-03 Alk-Abelló S.A. Novel manner of administrating allergen in allergen specific immunotherapy
CN102584966A (zh) * 2011-11-14 2012-07-18 广州医学院第二附属医院 一种重组花生过敏原与突变体及其制备方法和应用
CN102603879A (zh) * 2012-03-30 2012-07-25 广州医学院第二附属医院 一种重组大豆过敏原与突变体及其制备方法和应用
CN102690340A (zh) * 2012-03-30 2012-09-26 广州医学院第二附属医院 一种重组巴西坚果过敏原与突变体及其制备方法和应用
CN102617719A (zh) * 2012-03-30 2012-08-01 广州医学院第二附属医院 一种重组大米过敏原与突变体及其制备方法和应用
CN102617715A (zh) * 2012-03-30 2012-08-01 广州医学院第二附属医院 一种重组真菌主要过敏原与突变体及其制备方法和应用
CN102675439A (zh) * 2012-03-31 2012-09-19 广州医学院第二附属医院 一种重组黑麦草花粉过敏原与突变体的制备方法和应用
EP2952200A1 (en) 2014-06-04 2015-12-09 Alk-Abelló A/S Allergen for prophylactic treatment of allergy
CN111187606B (zh) * 2020-02-25 2022-06-14 江苏海洋大学 一种用于海水基可循环清洁压裂液的表面活性剂及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5804201A (en) * 1996-03-11 1998-09-08 The Rockefeller University Immunomodulatory peptides of vespid antigen 5
ATE430199T1 (de) * 1998-01-31 2009-05-15 Univ Arkansas Verfahren und reagenzien zur verminderung der klinischen reaktion zur allergie
IT1318692B1 (it) * 2000-09-12 2003-08-27 Consiglio Nazionale Ricerche Varianti di proteine allergeniche di phleum pratense.

Also Published As

Publication number Publication date
HUP0101464A3 (en) 2004-10-28
KR20010041918A (ko) 2001-05-25
DK1062341T3 (da) 2008-11-03
ES2313776T3 (es) 2009-03-01
ATE408690T1 (de) 2008-10-15
IL138339A (en) 2009-06-15
CA2323687C (en) 2008-11-25
JP2002506648A (ja) 2002-03-05
EP1062341B1 (en) 2008-09-17
US20040091500A1 (en) 2004-05-13
CA2323687A1 (en) 1999-09-23
PL194804B1 (pl) 2007-07-31
EP1062341A1 (en) 2000-12-27
PT1062341E (pt) 2008-12-24
NO20004614L (no) 2000-10-26
CN1293710A (zh) 2001-05-02
CN1332029C (zh) 2007-08-15
NZ506665A (en) 2003-08-29
AU2714799A (en) 1999-10-11
NO328354B1 (no) 2010-02-01
IL138339A0 (en) 2001-10-31
HK1033591A1 (en) 2001-09-07
DE69939584D1 (de) 2008-10-30
PL343029A1 (en) 2001-07-30
NO20004614D0 (no) 2000-09-15
HUP0101464A2 (hu) 2001-08-28
WO1999047680A1 (en) 1999-09-23
AU749749B2 (en) 2002-07-04

Similar Documents

Publication Publication Date Title
IL138339A0 (en) Mutant recombinant allergens
HK1060371A1 (en) Mutant allergens
WO2003020889A3 (en) Methods of maturing plasmacytoid dendritic cells using immune response modifier molecules
MXPA04002593A (es) Composiciones y metodos para el diagnostico y tratamiento de tumor.
MXPA03011985A (es) Composiciones y metodos para el diagnostico y tratamiento de tumores.
CA2000786A1 (en) 3-piperidinyl-1,2-benzisoxazoles
WO2004024097A8 (en) Compositions and methods for the treatment of immune related diseases
WO2004047728A3 (en) Compositions and methods for the treatment of immune related diseases
HUP0302965A2 (hu) Vakcina
BG102818A (en) D-manitol and method for its preparation
AU3227700A (en) Skin sanitizing compositions
MX9708426A (es) Polipeptido hk2 de variante estable.
AU4011300A (en) Compositions and methods for the treatment of immune related diseases
ATE284708T1 (de) T-zellimpfung zur behandlung von multiple sclerosis
WO2004024072A3 (en) Novel compositions and methods for the treatment of immune related diseases
WO2001040465A3 (en) Compositions and methods for the treatment of immune related diseases
MXPA04001986A (es) Composiciones y metodos para el tratamiento de enfermedades relacionadas a la inmunidad.
WO2000015797A3 (en) Compositions and methods for the treatment of immune related diseases
IL153576A0 (en) Dna vaccines encoding hiv accessory proteins
NZ514027A (en) Cloning and expression of haemophilus somnus transferrin-binding proteins
AU7079300A (en) Compositions and methods for the treatment of immune related diseases
EP0821691A4 (en) METHOD FOR SYNTHESIS OF GM2
WO2004004649A3 (en) Compositions and methods for the treatment of immune related diseases
WO1999015160A3 (en) Use of 6,7-substituted 2-aminotetralines suitable for preparing pharmaceutical composition for the therapeutic treatment of inflammatory and/or autoimmune pathologies
WO2000027881A3 (de) Menschliche interleukin -10 mutantenproteine